NEXGEL INC. Announces the Commercial Launch of Consumer Products

LANGHORNE, PA / ACCESSWIRE / September 15, 2020 / NEXGEL, Inc. (“NEXGEL” or the “Company”), an innovative company developing ultra-gentle, high-water content E-beam hydrogels with a focus on the consumer over-the-counter, Rx, medical device and cosmetic markets, today announced that they have begun the launch of several proprietary products utilizing their hydrogel technology for various indications. Fever Cool, Hexagel, ClearComfort, and Nip Defense mark the beginning of the company’s commercial product strategy implementation. The following proprietary products are listed in their entirety for various indications:

  • Fever Cool is a hydrogel specifically created to help reduce fever temperatures. This non-medicated, 90% water patch, safely provides cooling while being safe to use with other medications. It is repositionable, skin-friendly, and very gentle on skin. 
  • Hexagel is a small hexagonal patch, made with deionized water and aloe, that instantly cools and soothes any spot on the body that has minor irritation. Hexagels are ideal for relief of bug-bites, blisters, minor burns, and protective face mask irritations. With its low adhesion and ultra-hydrating features, Hexagels are a must have in first aid kits and sports bags.
  • ClearComfort is a low profile and comfortable to wear blister shield patch used for preventing chafing and blisters predominately on the heels and feet. These patches are comfortable for longtime active wear without leaving irritating residue on shoes/coverings. ClearComfort is also the first of its kind to provide customers with a customizable sheet of gel to insure the ideal patch size for each unique foot need. 
  • Nip Defense is a nipple protective patch, for male long-distance runners to protect their nipples from chaffing, irritation, and bleeding. With this gel patch, there is no need for additional tape for adhesion. It is skin-friendly and comfortable for longtime wear.

These products will be added to the Sport Defense Product line of Dancer Dots, and Dancer Dot Minis in our catalogue, as well as on Amazon.

” We are very pleased with the growth of both Hexgels and Dancer Dots since their release on Amazon in July. With FeverCool, launching today, followed by a robust continuing product release schedule, this is a very exciting time for Nexgel and our opportunity for growth.” commented Adam Levy, NEXGEL’s Chief Executive Officer.

About NEXGEL, INC.

NEXGEL has been a leading provider of ultra-gentle, high-water content hydrogels to leading medical companies around the world. Based in Langhorne, Pennsylvania, we’ve been developing and manufacturing electron-beam cross-linked hydrogels for over 23 years. In that time, our team has formulated over 200 different combinations to bring some of the best over-the-counter, cosmetic, and natural ingredients to the skin in a gentle patch that can be worn for long periods of time with little to no irritation. NEXGEL, Your Skin Friendly Patch Co.

Forward Looking Statements

This press release contains certain forward-looking statements, including those relating to the Company’s product development, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statements that are predictive in nature. Additional written and oral forward-looking statements may be made by the Company from time to time in filings with the Securities and Exchange.

For more information, please contact:

William Odenthal
Director of Investment Banking
Alere Financial Partners
A Division of Cova Capital Partners,LLC
www.covacp.com
917-747-4762-CELL
wodenthal@alerefinancial.com

SOURCE: NEXGEL, Inc.

View source version on accesswire.com:
https://www.accesswire.com/606221/NEXGEL-INC-Announces-the-Commercial-Launch-of-Consumer-Products

Staff

Recent Posts

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

6 minutes ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

6 minutes ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

6 minutes ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

6 minutes ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

6 minutes ago

PulseAI Secures Seed Funding to Advance AI-Driven ECG Diagnostics

BELFAST, Northern Ireland  , Jan. 12, 2026 /PRNewswire/ -- PulseAI, a rapidly emerging leader in…

6 minutes ago